effects [qlco]
Hormone replacement therapy [topp]
Blood coagulation [ortf]
Fibrinolysis [phsf]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Introduction [hlca]
Hypertension [dsyn]
Estrogens [horm, phsu, strd]
investigated [ftcn]
hormone replacement [topp]
haemostatic [ortf]
Mild to moderate [qlco]
Essential [qlco]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Materials [sbst]
Methods [inpr]
Group [idcn]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Received [qlco]
hormone replacement [topp]
Conjugated [spco]
Equine [mamm]
mg/mg [qnco]
Plus [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
Daily [tmco]
months [tmco]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
hypertensive [fndg]
Women [popg]
Administered [ftcn]
Drugs [phsu]
Start [tmco]
Study [mnob]
haemostatic [ortf]
i e [diap, inpr]
Antithrombin [aapp, phsu]
Protein C Activity [lbpr]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
D-dimer [aapp, bacs]
Plasminogen [aapp, bacs, phsu]
Measured [qlco]
Plasma [bdsu]
Women [popg]
months [tmco]
Start [tmco]
Study [mnob]
Antithrombin [aapp, phsu]
Levels [qlco]
hypertensive [fndg]
Normotensive [fndg]
Women [popg]
Received [qlco]
hormone replacement [topp]
Decreased [qnco]
P NOS [aapp, imft]
months [tmco]
P NOS [aapp, imft]
P NOS [aapp, imft]
D-dimer [aapp, bacs]
months [tmco]
P NOS [aapp, imft]
Plasminogen [aapp, bacs, phsu]
Levels [qlco]
P NOS [aapp, imft]
months [tmco]
P NOS [aapp, imft]
Increased [qnco]
haemostatic [ortf]
Unchanged [fndg]
haemostatic [ortf]
Control Group [grup]
hormone replacement [topp]
months [tmco]
Activated [acty]
Blood coagulation [ortf]
Fibrinolysis [phsf]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Administration [ocac]
cee [orch]
Plus [qlco]
therapy [ftcn]
hypertensive [fndg]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Thromboembolic events [patf]
LTD [ortf]
Reserve [acty]
